Immunotherapy Success in Lung Cancer Sets Stage for Future Research
Published: Tuesday, Oct 22, 2019
Antoinette Wozniak, MD, FACP, FASCO
The emergence of immunotherapy agents in stage III non–small cell lung cancer (NSCLC) as well as small cell lung cancer (SCLC) treatment has led to improved survival outcomes, notes Antoinette Wozniak, MD, FACP, FASCO.
... to read the full story